Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001193125-26-038002

Chief Financial Officer sold 1,558 shares at $0.98 ($1,521)

  • Chief Financial Officer acquired 3,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Broadfoot Jill Marie · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-03 Exercise or conversion : show line 1 in the form +3,750 38,854 D
2026-02-04 Sale : show line 2 in the form −1,558 $0.98 $1,521 37,296 D
Open-market sales · 1,558 sh · avg $0.98 · $1,521

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 3 in the form Restricted Stock Unit −3,750 0 D
Loading xslF345X05/ownership.xml…